How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

18,657 results for

Medication Causes of Headache

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents. Full Text available with Trip Pro

and was frequently left untreated, views on children's pain have changed over time, and relief of pain is now seen as important.We designed a suite of seven reviews on chronic non-cancer pain and cancer pain (looking at antidepressants, antiepileptic drugs, non-steroidal anti-inflammatory drugs, opioids, and paracetamol) in order to review the evidence for children's pain utilising pharmacological interventions.As the leading cause of morbidity in the world today, chronic disease (and its associated pain (...) within paediatric pain management. Non-steroidal anti-inflammatory drugs are currently licensed for use in Western countries, however they are not approved for infants under three months old. The main adverse effects include renal impairment and gastrointestinal issues. Common side effects in children include diarrhoea, headache, nausea, constipation, rash, dizziness, and abdominal pain.To assess the analgesic efficacy and adverse events of NSAIDs used to treat chronic non-cancer pain in children

2017 Cochrane

82. Antiepileptic drugs for chronic non-cancer pain in children and adolescents. Full Text available with Trip Pro

been used to provide pain relief in adults for many chronic painful conditions and are now recommended for the treatment of chronic pain in the WHO list of essential medicines. Known side effects of antiepileptic drugs range from sweating, headache, elevated temperature, nausea, and abdominal pain to more serious effects including mental or motor function impairment.To assess the analgesic efficacy and adverse events of antiepileptic drugs used to treat chronic non-cancer pain in children (...) untreated, views on children's pain have changed over time, and relief of pain is now seen as importantWe designed a suite of seven reviews on chronic non-cancer pain and cancer pain (looking at antidepressants, antiepileptic drugs, non-steroidal anti-inflammatory drugs, opioids, and paracetamol) in order to review the evidence for children's pain utilising pharmacological interventions in children and adolescents.As the leading cause of morbidity in the world today, chronic disease (and its associated

2017 Cochrane

83. Non-steroidal anti-inflammatory drugs (NSAIDs) for cancer-related pain in children and adolescents. Full Text available with Trip Pro

treatments, or mucositis. However, this review focused on pain caused directly by the tumour itself such as nerve infiltration, external nerve compression, and other inflammatory events.Non-steroidal anti-inflammatory drugs (NSAIDs) are used to treat pain, reduce fever, and for their anti-inflammatory properties. They are commonly used within paediatric pain management. NSAIDs are currently licensed for use in western countries, however not approved for infants aged under three months. Primary adverse (...) effects include gastrointestinal issues and possible renal impairment with long term use. Other adverse effects in children include diarrhoea, headache, nausea, constipation, rash, dizziness, and abdominal pain.To assess the analgesic efficacy, and adverse events, of non-steroidal anti-inflammatory drugs (NSAIDs) used to treat cancer-related pain in children and adolescents aged from birth and 17 years, in any setting.We searched the Cochrane Central Register of Controlled Trials (CENTRAL) via

2017 Cochrane

84. Headaches Due to Low and High Intracranial Pressure. (Abstract)

Headaches Due to Low and High Intracranial Pressure. Headache disorders attributed to low and high intracranial pressure are commonly encountered in specialty headache practices and may occur more frequently than realized. While the headaches resulting from intracranial pressure disorders have what are conventionally thought of as defining characteristics, a substantial minority of patients do not manifest the "typical" features. Moreover, patients with intracranial pressure disorders may also (...) have a preexisting primary headache disorder. Heightening the complexity of the presentation, the headaches of intracranial pressure disorders can resemble the phenotype of a primary disorder. Lastly, patients with so-called intracranial "hypotension" often have normal CSF pressure and neuroimaging studies. Thus, a high index of suspicion is needed. The published literature has inherent bias as many types of specialists evaluate and treat these conditions. This article reviews the key points

2018 Continuum (Minneapolis, Minn.)

85. Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list. Full Text available with Trip Pro

) pathology of the immune system such as HIV; (15) painkiller overuse or new drug at onset of headache. Using the systematic SNNOOP10 list to screen new headache patients will presumably increase the likelihood of detecting a secondary cause. The lack of prospective epidemiologic studies on red flags and the low incidence of many secondary headaches leave many questions unanswered and call for large prospective studies. A validated screening tool could reduce unneeded neuroimaging and costs.© 2018 (...) Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list. A minority of headache patients have a secondary headache disorder. The medical literature presents and promotes red flags to increase the likelihood of identifying a secondary etiology. In this review, we aim to discuss the incidence and prevalence of secondary headaches as well as the data on sensitivity, specificity, and predictive value of red flags for secondary headaches. We review the following red flags

2018 Neurology

86. The Feasibility and Efficacy of Ultrasound-Guided C2 Nerve Root Coblation for Cervicogenic Headache. (Abstract)

collected retrospectively by reviewing the patient's medical records and pain questionnaires.A total of 109 patients with cervicogenic headache sustained for at least six months were identified. Of those patients, 26 had a visual analog scale score ≥6 and subsequently underwent an ultrasound-guided C2 nerve root coblation.All 26 patients had >50% pain relief one day after coblation. Twenty-three of the 26 patients (92.31%) had a decrease in their pain score of 50% or more at 24-week follow-up. The mean (...) The Feasibility and Efficacy of Ultrasound-Guided C2 Nerve Root Coblation for Cervicogenic Headache. The cervicogenic headache is a syndrome caused by dysfunction of the upper cervical spine and its component bony, disc, and/or soft tissue elements. The C2 nerve root may play a pivotal role in cervicogenic headache. In this retrospective study, we evaluated the feasibility and efficacy of ultrasound-guided C2 nerve root coblation in managing 26 patients with cervicogenic headache.The data were

2018 Pain Medicine

87. Pediatric headache: overview. (Abstract)

Pediatric headache: overview. Headache is a common medical complaint in children and adolescents with the majority having experienced some type of headache by their teenage years. Pediatric headache presentations often differ compared to adults, and children may have difficulty describing their symptoms. Thus, a thorough understanding of the approach to the pediatric headache patient is essential to ensure appropriate diagnosis, evaluation, and management.In the following article we will review (...) the components of a comprehensive pediatric headache assessment, as well as discuss primary and secondary headache types seen in children with focus on clinical pearls and 'red flags' necessitating diagnostic testing.Headaches in children may be due to primary or secondary etiologies. Common primary headache types include migraine or tension-type headache. Secondary headache causes are broad and include infections, trauma, vascular disorders, substance use/withdrawal, and psychiatric conditions. Current

2018 Current Opinion in Pediatrics

88. Prediction of Post-dural Puncture Headache in Parturients Undergoing Elective Caesarean Section

develops between 5 and 14 days after the technique however it may immediately occur after dural puncture but it is rare and should pay attention of the physician to alternative causes. The pain is increased by head movement, upright posture and relieved by lying down. It resolves either spontaneously within 7 days or within 48 h after effective treatment which is usually consists of fluid therapy, analgesics, sumatriptan and caffeine. Epidural blood patch remained the gold standard therapy (...) but it is an invasive technique. The exact etiology of PDPH is unknown; there is two hypothesis attempts to explain the cause. First it's known that dural tear leads to cerebrospinal fluid (CSF) leak and decreased volume of CSF result in intracranial hypotension which cause on pain sensitive intracranial structures that become stretched when assuming upright position result in pain. Second, intracranial volume is constant and equal to the sum of intracranial blood, CSF, and brain matter. After loss of CSF

2018 Clinical Trials

89. Primary Headache and Psychological Factors, Mental Functioning and Attachment Modalities.

is concerned. WHO estimates that 1.7-4% of the global adult population is affected by headache for at least 15 days a month. Headaches are disabling, for patients (pain, suffering, fatigue, unavailability ...) but also for society (socio-economic cost as frequent work stoppages and drug costs). They are a public health problem. In 2002, the High Authority of Health published its recommendations for the diagnosis and management of migraine patients. In addition, the French Society for Migraine and Headache (...) table for additional information Studies a U.S. FDA-regulated Drug Product: No Studies a U.S. FDA-regulated Device Product: No Keywords provided by Centre Hospitalier Universitaire de Besancon: psychological factors Additional relevant MeSH terms: Layout table for MeSH terms Headache Headache Disorders Headache Disorders, Primary Pain Neurologic Manifestations Signs and Symptoms Brain Diseases Central Nervous System Diseases Nervous System Diseases

2018 Clinical Trials

90. Introvision for Migraine and Headaches

prophylaxis (sports, relaxation techniques, …) Informed consent Exclusion Criteria: Other causes of headache, symptomatic headaches Other primary headaches such as Cluster headache, trigeminal neuralgia, idiopathic facial pain, new daily persistent headache Severe depression (more than 13 points in the Beck Depression inventory fast screen (BDI-FS) Drug - or alcohol abuse Non-compliance, especially significant missing entries in the headache diaries Active psychosis Contacts and Locations Go (...) by the patients themselves with a scale in the headache diary: weak (=1) , moderate (=2), severe (=3) headache. Scores may range from 1 to 3. Average headache intensity of the attacks per months will be compared three months after the last session of Introvision compared to the waiting list group before Introvison. acute medication per month [ Time Frame: approximately 4 months, experimental group compared to the waiting list group ] The number of days with acute medication against migraine attacks/headache

2018 Clinical Trials

91. Using the S100B Protein for Emergency Headache Management Care

/10 Blood sample can be taken within 1 hour following the emergency admission VAS > 6 or Glasgow < 8 Signed and dated informed consent by patient, or trusted person, or family Exclusion Criteria: Patient presenting headache after head trauma Pregnant or breastfeeding women Patient with a pathology causing the elevation of PS100B's rate such as Alzheimer's disease, Creuzfeld-Jacob's disease, Multiple Sclerosis, cerebral tumour, trisomy 21, melanoma (diabetes excluded) Patient covered by social (...) information Study Type : Observational Estimated Enrollment : 250 participants Observational Model: Cohort Time Perspective: Prospective Official Title: Improving the Headache Management Care in the Emergency Unit by Using a Biological Marker: S100B Protein. Actual Study Start Date : October 24, 2018 Estimated Primary Completion Date : November 1, 2019 Estimated Study Completion Date : November 1, 2019 Resource links provided by the National Library of Medicine related topics: related topics: Groups

2018 Clinical Trials

92. Salivary Inflammatory Markers in Tension Type Headache and Migraine

International Classification of Headache Disorders, 3rd edition (beta version) Exclusion Criteria: abnormal plasma CRP, Interleukin-1β and Interleukin-6 levels (>10 mg/L) smoking cigarettes > 1 pack/day; current pregnancy, lactation, or hormonal contraceptive use alcohol or substance abuse drug use such as anticoagulants, statins, or hormonal drugs anti-inflammatory therapy other primary or secondary headaches major psychiatric disease oral health problems. Contacts and Locations Go to Information from (...) information Study Type : Observational Estimated Enrollment : 90 participants Observational Model: Cohort Time Perspective: Prospective Official Title: Salivary Inflammatory Markers (Interleukin -1β, Interleukin -6, C- Reactive Protein) in Tension Type Headache and Migraine Actual Study Start Date : January 1, 2016 Estimated Primary Completion Date : December 30, 2019 Estimated Study Completion Date : February 28, 2020 Resource links provided by the National Library of Medicine related topics: related

2018 Clinical Trials

93. Efficacy of Kinesio Taping in Tension Type Headache

, Pain Threshold and Emotional Status in Tension Type Headache Actual Study Start Date : April 5, 2018 Actual Primary Completion Date : June 10, 2018 Estimated Study Completion Date : September 25, 2018 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: Kinesio taping In this study, Kinesio Tape Tex Gold® kinesio tape over lateral ankle (5cm*5m) is used. 36 participants were taped for the TTH.50-mm wide (...) targeting this area moderate or excessive nausea and vomiting with headache headache due to other causes (e.g., subarachnoid hemorrhage, cerebral hemorrhage, cerebral embolism, cerebral thrombosis, vascular malformation, arthritis, hypertension, or arteriosclerosis) have used prophylactic headache medications in the last 3 months neurological, mental, hemorrhagic disease, allergy, serious heart, liver, kidney and other organ deficiencies Contacts and Locations Go to Information from the National Library

2018 Clinical Trials

94. Mindfulness for female outpatients with chronic primary headaches: an internet-based bibliotherapy Full Text available with Trip Pro

Mindfulness for female outpatients with chronic primary headaches: an internet-based bibliotherapy Our aim was to investigate effectiveness of mindfulness by bibliotherapy on disability, distress, perceived pain and mindfulness in women with tension headaches and migraines. Primary headaches have been of great interest to mental health researchers because of the high prevalence, as well as significant disability and distress in the affected people. Despite the promising results of in-person (...) treatment and some limitations that such interventions may cause, patients may be encountered with problems when using health care services. The present study is a quasi-experimental randomized design with pre-test, post-test, and control group. The study population consisted of 1396 women with migraine headache referring to headache clinic of Baqiyatallah Hospital in Tehran. Of these, 30 patients (including tboh experimental and control group) were selected by objective sampling method and were

2018 European journal of translational myology Controlled trial quality: uncertain

95. Oral High-Dose Thiamine Improves the Symptoms of Chronic Cluster Headache Full Text available with Trip Pro

, in energetic metabolism, and in pain modulation, we treated a patient affected by cluster headache with oral high-dose thiamine. We report a 41-year-old man suffering from primary chronic cluster headache since the age of 15 years. The patient began oral therapy with high-dose thiamine in December 2016. Oral thiamine supplementation led to a dramatic improvement of the symptoms. The therapy was effective in reversing all the symptoms of the disease. Our observation suggests that a thiamine deficiency due (...) Oral High-Dose Thiamine Improves the Symptoms of Chronic Cluster Headache Cluster headache is a rare painful primary disorder occurring in either episodic or chronic patterns. Several authors found that the hypothalamus, the brain region regulating endocrine function and autonomic system, is involved in the pathophysiology of cluster headache. Some authors have found in patients affected by this disease abnormality in glucose metabolism. Considering the role of thiamine in brain function

2018 Case reports in neurological medicine

96. Patient with a Subarachnoid Headache Full Text available with Trip Pro

Patient with a Subarachnoid Headache Subarachnoid hemorrhage (SAH) is a life-threatening cause of headache. The diagnostic approach to this entity continues to evolve with a recent questioning of the classic workup of computed tomography and lumbar puncture. We report a risk management case of a patient with a missed SAH resulting in a fatal outcome. When there are multiple diagnostic strategies, the patient may be involved with shared decision-making. Some of the medical and legal implications

2018 Clinical Practice and Cases in Emergency Medicine

97. Prediction of vascular abnormalities on CT angiography in patients with acute headache Full Text available with Trip Pro

Prediction of vascular abnormalities on CT angiography in patients with acute headache Patients with acute headache increasingly undergo CT-angiography (CTA) to evaluate underlying vascular causes. The aim of this study is to determine clinical and non-contrast CT (NCCT) criteria to select patients who might benefit from CTA.We retrospectively included patients with acute headache who presented to the emergency department of an academic medical center and large regional teaching hospital (...) and underwent NCCT and CTA. We identified factors that increased the probability of finding a vascular abnormality on CTA, performed multivariable regression analyses and determined discrimination with the c-statistic.A total of 384 patients underwent NCCT and CTA due to acute headache. NCCT was abnormal in 194 patients. Among these, we found abnormalities in 116 cases of which 99 aneurysms. In the remaining 190 with normal NCCT we found abnormalities in 12 cases; four unruptured aneurysms, three cerebral

2018 Brain and behavior

98. Effect of Soft Tissue Techniques on Headache Impact, Disability, and Quality of Life in Migraine Sufferers: A Pilot Study. (Abstract)

improved only in the experimental group (p < 0.001).Soft tissue techniques based on MTrP therapy and stretching were helpful for improving certain aspects of migraine, such as the impact and disability caused by the headache, and the frequency and intensity of headache; however, when combined with suboccipital soft tissue inhibition, the treatment effect was larger. (...) Effect of Soft Tissue Techniques on Headache Impact, Disability, and Quality of Life in Migraine Sufferers: A Pilot Study. To determine the efficacy of suboccipital inhibitory techniques in people with migraine compared with a control treatment based on myofascial trigger point (MTrP) therapy and stretching.A randomized, double-blind controlled pilot trial was conducted.University research laboratory.Forty-six adults diagnosed with migraine with over 6 months duration.Participants were

2018 Journal of Alternative and Complementary Medicine Controlled trial quality: predicted high

99. Diagnosis and Management of Headache in Older Adults. Full Text available with Trip Pro

Diagnosis and Management of Headache in Older Adults. Headache is a common, disabling neurologic problem in all age groups, including older adults. In older adults, headache is most likely a primary disorder, such as tension-type headache or migraine; however, there is a higher risk of secondary causes, such as giant cell arteritis or intracranial lesions, than in younger adults. Thus, based on the headache history, clinical examination, and presence of headache red flags, a focused diagnostic (...) evaluation is recommended, ranging from blood tests to neuroimaging, depending on the headache characteristics. Regardless of the primary or secondary headache disorder diagnosis, treatment options may be limited in older patients and may need to be tailored to the presence of comorbid medical conditions. The purpose of this review is to provide an update on the management of headache in older adults, from diagnosis to treatment.Copyright © 2017 Mayo Foundation for Medical Education and Research

2018 Mayo Clinic Proceedings

100. Benign Headache Management in the Emergency Department. (Abstract)

inflammatory drugs or acetaminophen. Dexamethasone can be used for the reduction of headache recurrence. If dehydration is present, intravenous fluids should be provided. Diphenhydramine is not recommended for analgesia but may reduce akathisia associated with prochlorperazine. Ketamine, propofol, and nerve blocks demonstrate promise. Triptan agents are also efficacious, provided absence of contraindications. Most patients are appropriate for discharge with pain improvement.A variety of medications (...) Benign Headache Management in the Emergency Department. Headache is a common complaint managed in the emergency department (ED), with emergency physicians focusing on evaluation for life-threatening conditions while treating pain and nausea.This review evaluates the treatment of benign, primary headaches in the ED, with recommendations provided based on the literature.Headaches are a major cause of disability in the United States and a common condition managed in the ED. The primary objectives

2018 Journal of Emergency Medicine

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>